Search Results 101-110 of 18432 for crohn's disease

1. Treatment response and management of biologics in patients with ECD - Mayo Clinic

   Mayo Clinic researchers describe the clinical features and response to biologic treatment in patients with esophageal Crohn's disease (ECD), a rare Crohn's ...

2. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

   A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) · Overview.

3. Improving the Quality of Care for Adults with Inflammatory Bowel Disease - Mayo Clinic

   The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients and ...

4. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

   Understanding of how best to treat inflammatory bowel disease (IBD) ... Evidence now suggests that the most effective therapy early in the course of Crohn's ...

5. Patients with Inflammatory Bowel Disease Have Higher Risk of Melanoma - Mayo Clinic News Network

   More than 1.5 million Americans have Crohn's disease or ulcerative colitis, the most common forms of inflammatory bowel disease. Both conditions inflame the ...

6. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

   A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) · Overview · Participation eligibility · Participating Mayo Clinic ...

7. A Study to Evaluate Impact of COVID-19 on Inflammatory Bowel Disease - Mayo Clinic

   The purpose of this study is to understand the impact of the COVID pandemic on IBD patients, including infection rates and complications from SARS-COV2, IBD ...

8. Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease - Mayo Clinic

   ... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

9. Adverse effects related to Heplisav-B vaccination in patients with Inflammatory Bowel Disease - Mayo Clinic

   ... Crohn's disease. This new vaccine has been found to be more effective than ... IBD and chronic liver disease. In this study, we aim to collect data on ...

10. Mayo Clinic Biobank - Autoimmune Disorders

    She has requested samples from 100 Biobank participants without a history of inflammatory bowel disease, celiac disease or irritable bowel syndrome to compare ...